First-Line Nivolumab Plus Chemo Approved for Bladder Cancer Combination reduced risk of death by 22% Mar 07, 2024
First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy Mar 07, 2024
A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patients Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab Mar 06, 2024
FDA OKs First Interchangeable Biosimilars for Denosumab New products will carry all the same indications as Prolia and Xgeva, though launch date unclear Mar 06, 2024
King Charles' Cancer Diagnosis Highlights Long Wait Times Across the Pond Survival for common cancers in the U.K. consistently lags behind Mar 06, 2024
IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubt "Every month that you're not pregnant feels like grief" Mar 05, 2024
All-Oral AML Regimen Shows Promise for Older, Unfit Patients Response rate of 64% in newly diagnosed patients, 46% in those with refractory/relapsed disease Mar 05, 2024
More Evidence Linking H. Pylori Infection to Colorectal Cancer Increased CRC incidence and mortality, significantly reduced by infection treatment Mar 05, 2024
Novel Therapy Promising for Radiation-Induced Oral Mucositis No patient with head and neck cancer developed a severe case during 7 weeks of treatment Mar 04, 2024
Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer Few responses with or without guidance in small first step for "personalized" treatment Mar 04, 2024
FDA OKs Amivantamab as First-Line Lung Cancer Treatment Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations Mar 04, 2024
Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Update The EPA is set to take action after public outcry Mar 03, 2024
Taking Control of the Cancer Journey Kathy Giusti gives patients and healthcare workers advice for navigating cancer treatment Mar 02, 2024 podcast
Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCC Local control in 91% of cases at 1 year in small prospective trial Mar 01, 2024
Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results One first-line regimen led to worse OS, while another offers an additional option Mar 01, 2024
New Drugs Yield Limited Benefit; Big Jump in Drug Prices; AI Boost for Mammo Results News, features, and commentary about cancer-related issues Mar 01, 2024
When a Neurologist Asks for an MRI, You Order an MRI "This was going to be a lifelong battle" Mar 01, 2024 podcast
Robotic Surgery for Pancreatic Tumors Proves Safe, Feasible in Experienced Hands Shorter stays, faster surgeries, and less blood loss versus open surgery in Chinese study Feb 29, 2024
Study Tests Office-Based Transperineal Approach to Prostate Biopsies Antibiotic-free option resulted in zero infections in randomized trial Feb 29, 2024 video
Cancer Prevention Strategies Linked to Mortality Reduction in BRCA Carriers Cohort studies indicate oophorectomy, breast MRI surveillance save lives, researchers say Feb 29, 2024
PROs for Cutaneous Chronic GVHD After Transplant Tied to Disease Severity, Mortality Baseline QOL, symptom burden could inform risk stratification, treatment decisions Feb 28, 2024
In TNBC, Pathologic Complete Response May Vary by Race/Ethnicity Compared with white women, Black women less likely and Hispanic women more likely to achieve pCR Feb 27, 2024
Oregon Pathologist Reportedly Missed Cancer Diagnoses One patient received the news that she had cancer a year after breast biopsy Feb 27, 2024
More Population-Based Evidence That Screening for CRC Reduces Risk of Cancer Death Large Swedish study shows 14% reduction in long-term CRC mortality, 16% reduction in all deaths Feb 27, 2024
Investigational Immunotherapy Combo Shows Promise for Advanced Solid Tumors Objective response rate of 37.7% in patients with various solid tumors in phase I study Feb 26, 2024
Amy Schumer's Diagnosis; FDA Yanks Cancer Drug; Nursing Student Murdered Health news and commentary from around the Web gathered by ΒιΆΉ΄«Γ½ staff Feb 26, 2024
Can Artificial Intelligence Improve Prior Authorization? Possibly, but "complete transparency" about its use would be needed, expert says Feb 23, 2024
Changing the Surgical Paradigm in Oligometastatic NSCLC Propensity-score matched analysis suggests survival benefit with surgery to the primary tumor Feb 23, 2024
Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warning News, features, and commentary about cancer-related issues Feb 23, 2024
Faster Cures, More Genetic Treatments: A Q&A With NIH's Joni Rutter The NCATS Biomedical Data Translator is giving researchers ideas for new disease therapies Feb 23, 2024
Make the Diagnosis: A Blue-Black Facial Nodule -- What's Your Best Guess? A 64-year-old postal worker visited his doctor about a lesion that he first noticed on his face 2 months prior. Can you diagnose the patient? Feb 23, 2024
Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
Male Fertility Problems in the Family Linked to Cancer Risk Low sperm levels were tied to specific cancers in family members Feb 22, 2024
Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD Feb 22, 2024 video
Elotuzumab Misses Mark Again as Frontline Treatment for Multiple Myeloma No PFS benefit from adding the monoclonal antibody to standard therapy Feb 20, 2024
Annual Breast Cancer Screening Starting at Age 40 Best, Modeling Study Says Estimates suggest mortality was reduced by 42% with annual screening for this age group Feb 20, 2024
For Kids With Sickle Cell Disease Prescribed Opioids, No Patterns of Misuse Emerged Number of vaso-occlusive crises tied to days' supply Feb 19, 2024
Radioligand Therapy Continues to Show Promise for Metastatic CRPC Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients Feb 16, 2024
FDA OKs First Cellular Therapy for Melanoma Lifileucel approved as treatment for advanced melanoma after anti-PD-1 and targeted therapy Feb 16, 2024
